Biggest News Aggregation in the World
๐Ÿ“ฐ Associate Chief News

Page 18 - Associate Chief News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Associate Chief. Real-time updates on events, politics, business and more.

John J. Pershing VA Medical Center prepares for COVID-19 vaccine arrival

John J. Pershing VA Medical Center prepares for COVID-19 vaccine arrival John J. Pershing VA Medical Center prepares for COVID-19 vaccine arrival By Isabelle Hanson | December 17, 2020 at 4:50 PM CST - Updated December 18 at 4:41 AM POPLAR BLUFF, Mo. (KFVS) - Healthcare workers at John J. Pershing VA Medical Center could receive their first shipment of COVID-19 vaccines as early as Tuesday, December 22. โ€œI think thereโ€™s gonna be a lot of relief once this Moderna vaccine is approved and...
Balamurugan Krishnan Specialty Services Johnj Pershing Va Medical Center Bailey Wells Christmas Eve Associate Chief
Source: kfvs12.com

Now Announcing: The Ai4 2021 Cybersecurity Summit Speaker Lineup

Now Announcing: The Ai4 2021 Cybersecurity Summit Speaker Lineup The fully-digital Ai4 2021 Cybersecurity Summit will gather 50+ speakers from the worlds most innovative companies. NEW YORK, NEW YORK, USA, December 15, 2020 /EINPresswire.com/ -- The fully-digital Ai4 2021 Cybersecurity Summit will gather 50+ speakers from the worlds most innovative companies on February 3-4, 2021. With over 40 hours of content across 4 tracks itโ€™s too much for any one p...
United States Mark Sherman Januarius Asongu Garfield Jones Kyle Reidell Mahasa Zahirnia

Agendia, Inc.: Results from APHINITY Trial using BluePrint as a Biomarker Assay Presented at SABCS in Poster Spotlight Discussion

(1) Agendia and Roche evaluate BluePrints stratification of HER2+ early breast cancer patients treated with adjuvant pertuzumab Agendia, Inc., a world leader in precision oncology for breast cancer, today announced data from the APHINITY trial in a poster spotlight discussion at the 2020 San Antonio Breast Cancer Symposium (SABCS 2020). The poster, titled Prediction of benefit from adjuvant pertuzumab by BluePrint RNA sequencing in the APHINITY trial, outlines data from an exploratory anal...
United States Ian Krop Adam Brufsky Terri Clevenger Division Of Breast Oncology University Of Pittsburgh School Medicine

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science